Buprenorphine Access Workgroup

As required by Maryland House Bill 1131 of 2025, Maryland’s Office of Overdose Response is convening a workgroup to study access to buprenorphine in the state. The workgroup will examine a variety of topics related to the current status of buprenorphine services in Maryland, including access to care, regions with gaps in services, funding, innovative strategies to expand access, and more. The workgroup shall submit its findings to the Governor and General Assembly by December 31st, 2025.

This meeting will be held virtually and is open to the public.

Meeting Details:
Date & Time: Tuesday, July 8, 2025 (4–5 pm)

Recording | Meeting Agenda